Voyager Therapeutics Inc (VYGR) Insider Trading
- $92,031,920.32
- $16,140,019.47
- Oct. 2, 2024
- Bernard Ravina
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Sept. 10, 2018 | Director | 3,000 | $19.39 | Buy | $58,170.00 | |
| Aug. 17, 2018 | Director | 3,000 | $18.31 | Buy | $54,930.00 | |
| April 10, 2018 | Insider | 2,451 | $18.38 | Sell | $45,049.38 | |
| March 23, 2018 | CFO | 11,200 | $20.52 | Sell | $229,824.00 | |
| March 19, 2018 | CFO | 17,316 | $22.11 | Sell | $382,856.76 | |
| March 16, 2018 | CFO | 15,416 | $22.15 | Sell | $341,464.40 | |
| March 12, 2018 | Insider | 2,451 | $25.16 | Sell | $61,667.16 | |
| Feb. 27, 2018 | Insider | 15,623 | $30.00 | Sell | $468,690.00 | |
| Feb. 12, 2018 | Insider | 2,451 | $18.24 | Sell | $44,706.24 | |
| Jan. 10, 2018 | Insider | 3,630 | $16.40 | Sell | $59,532.00 | |
| Dec. 11, 2017 | Insider | 5,490 | $13.63 | Sell | $74,828.70 | |
| Nov. 10, 2017 | Insider | 5,490 | $13.26 | Sell | $72,797.40 | |
| Oct. 10, 2017 | Insider | 10,980 | $20.33 | Sell | $223,223.40 | |
| Sept. 11, 2017 | Insider | 16,470 | $12.87 | Sell | $211,968.90 | |
| Sept. 5, 2017 | Insider | 5,490 | $10.00 | Sell | $54,900.00 | |
| July 20, 2017 | Insider | 5,490 | $10.00 | Sell | $54,900.00 | |
| Jan. 14, 2016 | CEO | 10,000 | $14.07 | Buy | $140,700.00 |
Insiders are both buying and selling Voyager Therapeutics Inc stock.
The insider traders at Voyager Therapeutics Inc are: Bernard Ravina, Rock Ventures Iii L.P. Third, Robert W Hesslein, Todd Alfred Carter, Robin Swartz, Ecor1 Capital, Llc, Jane Henderson, Neurocrine Biosciences Inc, Glenn Pierce, Andre Turenne, James A Geraghty, Julie Burek, Allison Dorval, Matthew P Ottmer, Dinah Ph.D. Sah, Higgins Michael J, Alfred Sandrock, Omar Khwaja, Peter P Pfreundschuh, PIERCE GLENN, Sandell Jacquelyn Fahey, and Steven M Paul
The most active insider trader at Voyager Therapeutics Inc is Bernard Ravina with 10 trades.
Rock Ventures Iii L.P. Third has sold the most Voyager Therapeutics Inc stock with a total value of $9,263,849.52.
Neurocrine Biosciences Inc has bought the most Voyager Therapeutics Inc stock with a total value of $128,055,189.76.
The most recent insider trade for Voyager Therapeutics Inc was on Oct. 2, 2024.
The single biggest insider buy for Voyager Therapeutics Inc was from Neurocrine Biosciences Inc with a total value of $49,989,546.88 on March 12, 2019.
The single biggest insider sell for Voyager Therapeutics Inc was from Ecor1 Capital, Llc with a total value of $3,497,520.00 on Jan. 9, 2023.